D Galetta
Overview
Explore the profile of D Galetta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
265
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reale M, Passiglia F, Cappuzzo F, Minuti G, Occhipinti M, Bulotta A, et al.
ESMO Open
. 2024 Aug;
9(9):103680.
PMID: 39214048
Background: Mesenchymal-epithelial transition (MET) exon 14 (METex14) skipping mutation is a rare alteration in non-small-cell lung cancer (NSCLC), occurring in about 3%-4% of cases. Here we report disease and patient...
2.
Avancini A, Giannarelli D, Borsati A, Carnio S, Cantale O, Nepote A, et al.
ESMO Open
. 2024 Jun;
9(7):103624.
PMID: 38943736
Background: Evidence demonstrates that physical exercise confers several psycho-physical benefits on patients with cancer. This study aims to investigate the role of oncologists in exercise promotion. Patients And Methods: A...
3.
Besse B, Felip E, Garcia Campelo R, Cobo M, Mascaux C, Madroszyk A, et al.
Ann Oncol
. 2023 Sep;
34(10):920-933.
PMID: 37704166
Background: Patients with advanced non-small-cell lung cancer (NSCLC) treated with immune checkpoint blockers (ICBs) ultimately progress either rapidly (primary resistance) or after durable benefit (secondary resistance). The cancer vaccine OSE2101...
4.
Di Stasio G, Travascio L, Colandrea M, Spaggiari L, Sorbello S, Ferrari M, et al.
Lung Cancer
. 2021 Jun;
158:40-46.
PMID: 34111568
Objectives: Pleomorphic lung carcinoma (PLC) is a rare histotype of non-small cell lung cancer (NSCLC) characterized by aggressive clinical course, poor response to therapy and poor prognosis. Therefore, aim of...
5.
Metro G, Gili A, Signorelli D, De Toma A, Garaffa M, Galetta D, et al.
Clin Transl Oncol
. 2021 Mar;
23(9):1818-1826.
PMID: 33728869
Introduction: The efficacy of immune checkpoint inhibitors in patients with brain metastases (BMs) from non-oncogene addicted non-small cell lung cancer (NSCLC) is under investigation. Here, we sought to determine the...
6.
Gobbini E, Chiari R, Pizzutillo P, Bordi P, Ghilardi L, Pilotto S, et al.
Clin Transl Oncol
. 2019 Oct;
22(3):294-301.
PMID: 31630357
Purpose: Anaplastic lymphoma kinase (ALK) rearrangement confers sensitivity to ALK inhibitors (ALKis) in non-small-cell lung cancer (NSCLC). Although several drugs provided an impressive outcome benefit, the most effective sequential strategy...
7.
Cortellini A, Leonetti A, Catino A, Pizzutillo P, Ricciuti B, De Giglio A, et al.
Clin Transl Oncol
. 2019 Aug;
22(6):844-851.
PMID: 31392645
Background: In most cases, T790M EGFR-positive NSCLC patients receiving osimertinib developed "non-drugable" progression, as the patients with common EGFR-sensitizing mutations were treated with first-line osimertinib. In both settings, chemotherapy represents...
8.
Carnio S, Galetta D, Scotti V, Cortinovis D, Antonuzzo A, Pisconti S, et al.
Support Care Cancer
. 2017 Dec;
26(6):1841-1849.
PMID: 29270827
Purpose: Chemotherapy-induced nausea and vomiting (CINV) still represents a common side-effect of chemotherapy, and often, its perception differs between patients and healthcare professionals. The aim of this study was to...
9.
Petriella D, De Summa S, Lacalamita R, Galetta D, Catino A, Logroscino A, et al.
Tumour Biol
. 2015 Nov;
37(4):5503-13.
PMID: 26566629
In NSCLC, the altered expression of some miRNAs in primary tumor tissues has been correlated with diagnosis and prognosis, while the role of circulating miRNAs as cancer biomarkers is currently...
10.
Gasparri R, Rezende G, Fazio N, Maisonneuve P, Brambilla D, Travaini L, et al.
Q J Nucl Med Mol Imaging
. 2015 Sep;
59(4):446-54.
PMID: 26416036
Aim: The role of fluorodeoxyglucose positron emission tomography (FDG-PET) as an additional investigation to computer tomography for pulmonary carcinoid tumors remains controversial. The aim of this study was to assess...